Patients HCP
This site is for US residents only.
Blue to magenta gradient.

Stay up to date
on the latest with
RHAPSIDO® (remibrutinib)

Even more support—straight to your inbox

We're here to provide information and support. Sign up to get the latest on chronic hives with no known external triggers and RHAPSIDO delivered right to you. 

Here's what to expect: 

  • Deeper understanding of chronic hives with no known external triggers: Access reliable and helpful information about your condition

  • Connection to a supportive community: Discover resources to help you navigate your treatment journey and hear from people also living with chronic hives with no known external triggers

  • Find out how RHAPSIDO may help you: RHAPSIDO is a prescription medicine used to treat adults with chronic spontaneous urticaria (CSU) who have symptoms of hives and itch despite treatment with antihistamines. It is not used to treat any other forms of hives (urticaria)

Sign up

*Required Fields

Which of the following best describes you? (select one) *

By clicking Submit, you agree that you are 18 years or older and agree to the Novartis Pharmaceuticals Corporation (NPC) Terms of Use. You understand and agree that the information you provided will be used in accordance with the NPC Privacy Policy, including to provide you with marketing information, offers, and promotions, and to contact you for your opinions regarding products, programs, and services. NPC may also show you relevant health-related advertisements when you visit other websites. To learn about our interest-based ads, click here. You understand that unless you unsubscribe, by calling 1-888-669-6682 or clicking unsubscribe in a promotional email, your consent will remain valid.

*Limitations apply. Subject to annual co-pay benefit limit. Offer not valid under Medicare, Medicaid, or any other federal or state programs. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at rhapsido.com for details.